Table 1 The clinicopathological characteristics of patients
pNEN (N=563) | SPT (N=30) | P-value | |
|---|---|---|---|
Age (Mean±SD, years) | 57.40±16.61 | 33.30±15.15 | < 0.001* |
Gender | < 0.001# | ||
Male | 315 (56.0%) | 2 (6.7%) | |
Female | 248 (44.0%) | 28 (93.3%) | |
Race | 0.403$ | ||
White | 419 (74.4%) | 19 (63.3%) | |
Black | 51 (9.1%) | 4 (13.3%) | |
Other | 93 (16.5%) | 7 (23.3%) | |
Location | 0.304$ | ||
Head | 160 (28.4%) | 8 (26.7%) | |
Body/Tail | 267 (47.4%) | 18 (60.0%) | |
Other | 136 (24.2%) | 4 (13.3%) | |
Tumor Size (mm) | 41.07±30.77 | 35.33±28.61 | 0.318* |
T-Stage | < 0.001$ | ||
T1-Stage | 114 (21.3%) | 2(6.7%) | |
T2-Stage | 172 (32.1%) | 21(70.0%) | |
T3-Stage | 151(28.2%) | 5(16.7%) | |
T4-Stage | 46(8.6%) | 2(6.7) | |
Tx-Stage | 80 (14.2%) | 0 (0.0%) | |
N-Stage | < 0.001$ | ||
N0-Stage | 329 (58.4%) | 29 (96.7%) | |
N1-Stage | 163 (29.0%) | 1 (3.3%) | |
Nx-Stage | 71 (12.6%) | 0 (0.0%) | |
M-Stage | < 0.001$ | ||
M0-Stage | 284 (50.4%) | 27 (90.0%) | |
M1-Stage | 279 (49.6%) | 3 (10.0%) | |
AJCC-Stage | < 0.001$ | ||
I-Stage | 170 (30.2%) | 23 (76.7%) | |
II-Stage | 101 (17.9%) | 4 (13.3%) | |
III-Stage | 13 (2.3%) | 0 (0.0%) | |
IV-Stage | 292 (49.6%) | 3 (10.0%) | |
Grade | 0.019$ | ||
Well differentiated | 210 (37.3%) | 5 (16.7%) | |
Moderately differentiated | 75 (13.3%) | 4 (13.3%) | |
Poorly differentiated | 35 (6.2%) | 0 (0.0%) | |
Undifferentiated | 14 (2.5%) | 0 (0.0%) | |
Unknown | 229 (40.7%) | 21 (70.0%) |